Annotation Detail for ADCY10

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa00230 | Purine metabolism |
| Pathway ID | Pathway Name |
|---|
| P00039 | Metabotropic glutamate receptor group III pathway |
| P00019 | Endothelin signaling pathway |
| P00040 | Metabotropic glutamate receptor group II pathway |
| P00043 | Muscarinic acetylcholine receptor 2 and 4 signaling pathway |
| Desease Name |
|---|
| Hypercalciuria, absorptive, susceptibility to |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ADCY10 mRNA | affects expression | 16483693
|
| D005419 |
Flavonoids |
Flavonoids results in increased expression of ADCY10 mRNA | increases expression | 18035473
|
| C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ADCY10 mRNA | increases expression | 16221955
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
| MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
4.06 | 17259670 12083418 |
| MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
4.75 | 3609246 |
| MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
4.21 | 12083418 |
| OMIM:143870 |
HYPERCALCIURIA, ABSORPTIVE, 2 |
marker/mechanism |
|
| |
| MESH:D007249 |
Inflammation |
|
Flavonoids |
6.10 | 17296493 |
| MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
6.10 | 12083418 |
| MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.97 | 8812269 |
| MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
3.04 | 14757943 18709148 |
| MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.61 | 9802331 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
5.14 | 17132714 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:00230 |
Purine metabolism |